Description
Fezolinetant
Each film-coated tablet contains: Fezolinetant … 45mg.
INDICATION
LuciFezo is a neurokinin 3 (NK3) receptor antagonist indicated for the treatment of moderate to severe vasomotor symptoms due to menopause.
DOSAGE AND USE
Perform baseline bloodwork to evaluate for hepatic function and injury before beginning LuciFezo While using LuciFezo, perform follow -up bloodwork at 3 months, 6 months, and 9 months after initiation of therapy and when symptoms suggest liver injury. One 45 mg tablet orally once daily with or without food.
STORAGE
In a dry place and store at 20°C to 25°C.
MANUFACTURED AND MARKETED BY
LUCIUS PHARMACEUTICALS(LAO) CO., LTD No.26, Thongmang village, Xaythany district, Vientiane Capital, Laos
WARNING
Keep medicine out of reach of Children. Do not administer LuciFezo during Pregnancy and Lactation.
Reviews
There are no reviews yet.